HCW Biologics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $426 | $618 | $1,126 | $1,324 |
Gross Profit | 85 | 180 | 371 | 252 |
EBITDA | -3,550 | -14,990 | -7,224 | |
EBIT | -3,678 | -15,120 | -7,468 | |
Net Income | -3,902 | -15,280 | -7,468 | -10,680 |
Net Change In Cash | 426 | 618 | 1,126 | 1,324 |
Free Cash Flow | -2,963 | -4,843 | -3,733 | -7,610 |
Cash | 998 | 1,161 | 4,084 | 3,595 |
Basic Shares | 37,823 | 37,823 | 37,223 | 36,025 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $2,841 | $6,722 | $4,099 | $4,099 |
Gross Profit | 560 | 2,586 | -543 | 4,099 |
EBITDA | -23,576 | -14,184 | -12,824 | -5,251 |
EBIT | -24,711 | -14,774 | -13,367 | -5,824 |
Net Income | -24,994 | -14,722 | -12,357 | -5,779 |
Net Change In Cash | 2,841 | 6,722 | 4,099 | 4,099 |
Cost of Revenue | 10,595 | |||
Free Cash Flow | -28,716 | -20,661 | -11,022 | -10,618 |
Cash | 3,595 | 22,326 | 11,730 | 8,455 |
Basic Shares | 35,929 | 35,822 | 35,768 | 36,700 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.10 |
2024-06-30 | -$0.40 |
2024-03-31 | -$0.30 |
2023-12-31 | -$0.30 |
